Hypothesis testing involves estimating the probability that observed results would have occurred by chance if a null hypothesis, which most commonly states that there is no difference between an intervention condition and a control condition, were true (see Chapter 28, Hypothesis Testing). In nursing research, we are accustomed to the reporting of probability (P) values and recognize the conventional threshold of P < 0.05 as one that signals a "significant difference" between groups. In other words, we can reject the null hypothesis and conclude that the difference observed is not compatible with chance. When we see values such as P < 0.01 and P < 0.001, we feel even more confident in rejecting the null hypothesis and sometimes describe the differences as "highly significant."
However, use of the hypothesis testing framework and P values has limitations. First, when a trial fails to reject the null hypothesis (i.e., when P > 0.05), the investigators may have missed an important intervention effect if the study was not large enough; a P value does not provide us with the information we need to determine the likelihood that, despite the lack of a statistically significant difference, a patient-important difference is still present. Second, use of a hypothesis testing framework produces a single value most likely to represent the true difference between the intervention and control groups. This value is only an estimate of the true difference, however, and the P value provides no information about the plausible range within which the true difference falls.
Consequently, an alternative approach, estimation through the use of confidence intervals, is becoming more popular. In this chapter, we define confidence intervals, illustrate how to interpret them, and outline the advantages of confidence intervals in determining whether the sample size of a study is large enough and in determining the importance of the results to patients. Numerous authors [1] [2] [3] [4] [5] have outlined the concepts that we introduce here, and you may find their discussions helpful in supplementing this chapter.
WHAT ARE CONFIDENCE INTERVALS?
The use of confidence intervals is an alternative approach that does not ask how compatible the results are with the null hypothesis. Rather, this approach poses the following question: Given the observed difference between the intervention and control groups, what is the plausible range of differences between the two groups within which the true difference may actually lie? We illustrate the use of confidence intervals with a coin-toss experiment.
Suppose we have a coin that may or may not be balanced. In other words, although the true probability of heads on any individual coin toss may be 0.5, the true probability may be as high as 1.0 in favor of heads (every toss will yield heads) or 1.0 in favor of tails (every toss will yield tails). We conduct an experiment to determine the true nature of the coin.
We begin by tossing the coin twice, observing one head and one tail. At this point, what is our best estimate of the probability of heads on any given coin toss? Our best estimate is the value we have obtained (otherwise known as the point estimate), which is 0.5. What is the plausible range within which the true probability of finding a head on any individual coin toss may lie? This range is very wide, and most people would think that the probability may still be as high as or higher than 0.9 or as low as or lower than 0.1. In other words, if the true probability of heads on any given coin toss is 0.9, it would not be surprising if any sample of two coin tosses resulted in one head and one tail. Hence, after two coin tosses, we are not much further ahead in determining the true nature of the coin.
We proceed with eight additional coin tosses. After a total of 10 tosses, we have observed five heads and five tails. Our best estimate of the true probability of heads on any given coin toss remains 0.5, the point estimate. The range within which the true probability of heads may plausibly lie has narrowed, however. It is no longer plausible that the true probability of heads is as great as 0.9. In other words, if the true probability were 0.9, it would be very unlikely that a sample of 10 coin tosses would result in five tails. Although people's sense of the range of plausible probabilities may differ, most would agree that probabilities greater than 0.8 or less than 0.2 are very unlikely.
After 10 coin tosses, all values between 0.2 and 0.8 are not equally plausible. The most likely value for the probability is the point estimate, 0.5, but probabilities close to that point estimate (e.g., 0.4 or 0.6) are also quite likely. The further the probability is from the point estimate, the less likely it is that the value represents the truth.
Ten coin tosses have still left us with considerable uncertainty about our coin, so we conduct another 40 repetitions. After 50 coin tosses, we have observed 25 heads and 25 tails, and our point estimate remains 0.5. We are now beginning to believe that the coin is very unlikely to be extremely biased, and our estimate of the range of probabilities, which is still reasonably consistent with 25 heads in 50 coin tosses, may be 0.35 to 0.65. This range still is quite wide, and we may persist with another 50 repetitions. If after 100 tosses, we observed 50 heads, we may guess that the true probability is unlikely to be more extreme than 0.40 or 0.60. If we were willing to endure the tedium of 1000 coin tosses and if we observed 500 heads, we would be very confident (but still not certain) that our coin is minimally, if at all, biased.
What we have done through this experiment is to use common sense to generate confidence intervals around an observed proportion, 0.5. In each case, the confidence interval represents the range within which the truth plausibly lies. The smaller the sample size is, the wider the confidence interval will be. As the sample size becomes very large, the confidence interval narrows, and we become increasingly certain that the truth is not far from the point estimate we have calculated from our experiment.
Because people's common sense differs considerably, we can turn to statistical techniques for precise estimation of confidence intervals. To use these techniques, we must first be more specific about what we mean by "plausible". In our coin-toss example, we could ask the following question: What is the range of probabilities within which the truth would lie 95% of the time? Table 29-1 6 presents the actual 95% confidence intervals around the observed proportion of 0.5 for our experiment. If we need not be quite so certain, we could ask about the range within which the true value would lie 90% of the time. This 90% confidence interval, also presented in Table 29 -1, is somewhat narrower.
The coin-toss example also illustrates how the confidence interval tells you whether the study is large enough to answer the research question. If you wanted to be reasonably certain that the true value was no more than 10% greater or smaller than the point estimate (i.e., the ends of the confidence interval are within 10% of the point estimate), you would need approximately 100 coin tosses. If you needed greater precision-with 3% in either direction-1000 coin tosses would be required. All you have to do to obtain greater precision is to make more measurements. In clinical research, this involves enrolling more patients.
USING CONFIDENCE INTERVALS TO INTERPRET THE RESULTS

OF CLINICAL TRIALS
How do confidence intervals help us to interpret the results of a trial? In a randomized controlled trial of 821 infants in a tertiary level neonatal intensive care unit, we compared care delivered by a team of clinical nurse specialists/neonatal practitioners (CNS/NPs) with that delivered by a team of pediatric residents. 7 During their stay in the neonatal unit, 19 of 414 infants (4.6%) assigned to the CNS/NP team died, as did 24 of 407 infants (5.9%) assigned to the pediatric resident team. The absolute difference of −1.3% is the point estimate, our best single estimate of the mortality benefit from using CNS/NPs. The 95% confidence interval around this difference is −4.4% to 1.7% (Table 29-2) .
How can we interpret these results? The most likely value for the absolute mortality difference between the two teams is 1.3% in favor of the CNS/NP team, but the true difference may be as high as 1.7% in favor of the pediatric resident team (i.e., in 100 patients, 1.7 fewer deaths in the pediatric resident team) or as high as 4.4% in favor of the CNS/NP team (i.e., in 100 patients, 4.4 fewer deaths in the CNS/NP team). In other words, the 95% confidence interval is consistent with the CNS/NP team having a reduction in mortality as high as 4.4% or an increase in mortality as high as 1.7% when compared with the pediatric resident team. Values progressively farther from 1.3% will be less and less probable. We can conclude that although we have failed to show important differences between the two teams, important differences in mortality in favor of the
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Chapter 29 435 CNS/NP team and in favor of the resident team remain plausible. To that extent, the sample size of this trial was not adequate to answer definitively the question of the relative mortality of the two approaches to care. This way of understanding the results avoids the yes/no dichotomy of hypothesis testing and obviates the need to argue whether a study should be considered positive or negative. One can conclude that, although it is most likely that the difference in mortality between the two approaches to care is small, an important difference in mortality remains plausible.
In the same trial, we also compared mean length of hospital stay in infants cared for by the CNS/NP team and those cared for by the pediatric resident team. The mean length of stay was 12.5 days in the CNS/NP group and 11.7 days in the pediatric resident group. The absolute difference of 0.8 days is our best single estimate of the benefit of being cared for by the pediatric resident team. The 95% confidence interval around this difference in means is −1.1 to 2.7 (see Table 29 -2).
How do we interpret these study results? The most likely value for the mean difference in hospital stay between the two teams is 0.8 days favoring the pediatric resident team, but the true difference may be as high as 2.7 days longer with the CNS/NP team (i.e., favoring the pediatric resident team). Alternatively, it remains plausible that care from the CNS/NP team results in average hospital stays up to 1.1 days shorter than the pediatric resident team (i.e., favoring the CNS/NP team).
In interpreting the results, you must ask yourself the following: If the CNS/NP team really results in longer hospital stays by an average of 2.7 days, would that represent an important benefit of using pediatric residents? Most of us would think a mean difference of 2.7 days is quite important. As a result, one must conclude that although we have failed to show an important difference in length of stay favoring either approach, the study has not excluded an important difference in length of stay in favor of the pediatric resident team.
The 95% confidence interval of −1.1 to 2.7 also includes a difference in mean number of hospital days of zero, signifying that it remains plausible that no difference actually exists in length of hospital stay between the two groups, (i.e., there was no statistically significant difference in length of hospital stay between the two groups). Indeed, people typically believe that studies that fail to show statistically significant differences have demonstrated that the groups did not differ. If you have understood what we have said about confidence intervals, you can see how badly mistaken it is to assume that the truth is "no difference."
When we understand confidence intervals, we realize just how much uncertainty exists, even when we have the results of randomized trials to inform us of important issues in managing patients or the health care system. At the same time, we must make choices, even in the face of uncertainty. It may be reasonable, then, to acknowledge that there may still be important differences between infants cared for by a CNS/NP team and those cared for by a pediatric resident team, but the results have failed to show such differences. Knowing that we may be wrong, and pending further evidence, we may operate under the assumption that the two approaches do not differ and make our choices accordingly.
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To summarize the study findings, our best estimate of the difference in mean length of stay indicates that infants cared for by the pediatric resident team were in hospital 0.8 days less than infants cared for by the CNS/NP team. The 95% confidence interval around this mean difference of −1.1 to 2.7 tells us that the true difference could be somewhere between a 2.7-day longer hospital stay with the CNS/NP team and a 1.1-day shorter hospital stay with the CNS/NP and could in fact be zero, reflecting no difference between groups. The width of this confidence interval is determined by the sample size of the study. Given that a difference in hospital stay as high as 2.7 days may be important, we conclude that the sample size of this trial was not adequate to answer definitively the question of the relative length of hospital stay in the two groups.
When examining confidence intervals around absolute risk differences in dichotomous variables (e.g., mortality) or continuous variables (e.g., length of hospital stay, quality of life scores, or patient satisfaction scores), a confidence interval around the difference that includes zero signifies that no difference between groups remains a plausible estimate of the true effect. In the CNS/NP trial, the confidence interval around the absolute risk difference for mortality of −1.3% (−4.4% to 1.7%) and the confidence interval around the mean difference in length of hospital stay of 0.8 days (−1.1 to 2.7) both include zero, indicating that no difference between groups is a plausible estimate of the true effects. Confidence intervals that include no difference between groups as a plausible estimate of the true effects are consistent with a value of P > 0.05, signifying no statistically significant difference between groups.
Conversely, when we use odds ratios or relative risks to determine differences between groups for dichotomous variables such as death, no difference between groups is a plausible estimate of the true effect if the confidence interval includes 1.0. For example, in the CNS/NP trial, the relative risk of mortality was 0.78 with a 95% confidence interval of 0.43 to 1.40 (see Table 29 -2), indicating there may be no difference in mortality between groups.
INTERPRETING APPARENTLY "NEGATIVE" TRIALS
When you see an apparently negative trial (one that fails to exclude the null hypothesis in the hypothesis testing framework), the confidence interval around the difference between groups will help you to determine whether the trial was indeed large enough to exclude a patient-important benefit. The CNS/NP trial provided a good example. Although the trial failed to show differences between the two groups (thus, it was a negative trial), it also failed to exclude the possibility of important differences in mortality and length of hospital stay.
We will use another example to further illustrate this issue. Until 1999, only four randomized controlled trials had compared magnesium sulfate with placebo or no anticonvulsant for prevention of eclampsia in women with preeclampsia. [8] [9] [10] [11] The four trials were small, including a total of 1112 women. Three (0.5%) of the 558 women allocated to magnesium sulfate had convulsions compared with 11 (2%) of the 554 women allocated to placebo or no anticonvulsant. The point estimate from these results is a 1.5% (2% minus 0.5%) absolute reduction in convulsions in the magnesium sulfate group. Meta-analysis of these four trials revealed a relative risk of 0.33 and a 95% confidence interval of 0.11 to 1.02. 12 This meta-analysis may appear to exclude a possible benefit from magnesium sulfate because the confidence interval includes a relative risk of 1.0, which means that the underlying possible truth still includes no difference in convulsions between the two groups. However, the confidence interval is wide. By subtracting the lower and upper boundaries of the confidence interval from 1.0, we can calculate the relative risk reduction that accompanies each boundary. We find that the truth lies somewhere between an 89% (1.00 minus 0.11) risk reduction of convulsions favoring the magnesium sulfate group (using the lower boundary of the confidence interval, i.e., 0.11) and a 2% (1.00 minus 1.02) increase in the risk of convulsions with magnesium sulfate favoring the control group (using the upper boundary of the confidence interval, i.e., 1.02). Note that subtracting 1.02 from 1.00 results in a negative risk reduction which translates into a risk increase. With the truth lying somewhere between an 89% risk reduction and a 2% risk increase, we can conclude that the trials individually or combined did not exclude a patient-important benefit and, in that sense, were not large enough.
This example emphasizes that many patients must participate if trials are to generate precise estimates of intervention effects. In 2002, a very large randomized controlled trial was published in which investigators allocated 5071 women in 33 countries to magnesium sulfate and 5070 women to placebo. 13 Fewer eclamptic convulsions occurred among women allocated to magnesium sulfate than among those allocated to placebo (0.8% versus 1.9%), resulting in a relative risk of 0.42 and a 95% confidence interval of 0.29 to 0.60, clearly favoring the intervention. Not surprisingly, when this large trial was included in an update of the systematic review described earlier, 14 the 95% confidence interval around the relative risk (0.41) was much tighter (0.29 to 0.58 compared with 0.11 to 1.02) and now excluded the possibility of no difference between groups. The relative risk and the accompanying confidence interval clearly favored magnesium sulfate over placebo in the prevention of eclamptic convulsions.
A confidence interval around a difference in an apparently negative trial can help to determine whether the trial is definitely negative. If the boundary of the confidence interval most in favor of the intervention excludes any important benefit of the intervention, you can indeed conclude the trial is definitely negative. Conversely, if the confidence interval includes an important benefit (as did the original meta-analysis of the four trials described earlier, 12 with a 95% confidence interval of 0.11 to 1.02), the trial has not ruled out the possibility that the intervention may still be worthwhile.
This logic of the negative trial is crucial in the interpretation of studies designed to help determine whether we should substitute an intervention that is less expensive, easier to administer, or less toxic for an existing intervention. In an equivalence study, such as the CNS/NP trial described earlier, 7 we will be ready to make the substitution only if we are sure that the standard intervention does not have important additional benefits beyond the less expensive or more convenient substitute. We will be confident that we have excluded the possibility of important additional benefits of the standard intervention if the upper boundary of the confidence interval around the difference is below our threshold. As we have shown, if we consider a mortality increase of 1.7% Unit V
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or an increase in length of stay of 2.7 days to be important, then the CNS/NP trial failed definitively to establish the CNS/NP team as an acceptable alternative to pediatric residents.
INTERPRETING APPARENTLY "POSITIVE" TRIALS
How can confidence intervals be informative in a positive trial (one that, in a hypothesis testing framework, makes chance an unlikely explanation for observed differences between interventions)? In a blinded (health care providers, data collectors, and data analysts) randomized controlled trial of mothers whose 6-to 12-month old infants had severe sleep problems, investigators compared a behavioral sleep intervention with a mailed fact sheet describing normal infant sleep patterns. 15 Twenty-three (30%) of 76 mothers in the behavioral sleep intervention group reported unresolved infant sleep problems at 2 months compared with 40 (53%) of 76 mothers in the mailed fact sheet (control) group. Expressing the results another way, the intervention reduced residual sleep problems from 53% to 30%. The relative risk of sleep problems is 30%/53% = 57%, and the 95% confidence interval around this relative risk is 38% to 86% (Table 29-3) . In other words, the risk of residual sleep problems in the behavioral sleep intervention group is a little over half (57%) of that in the mailed fact sheet group. Although our point estimate is 57%, the 95% confidence interval indicates that the true relative risk could be as low as 38% or as high as 86%. The relative risk reduction is 43% (1.0 minus relative risk or 1.0 minus 0.57). Using nontechnical language, we would say that the behavioral sleep intervention decreases the relative risk of sleep problems by 43% compared with the mailed fact sheet (see Chapter 27, Measures of Association). The 95% confidence interval around the relative risk reduction of 43% is 14% to 62%, a finding indicating that although our point estimate is 43%, the true relative risk reduction could be as low as 14% or as high as 62% (see Table 29 -3).
The point estimate of the absolute difference in infant sleep problem resolution is −23% (30% minus 53%), and the 95% confidence interval around this difference is −8% to −38% (see Appendix for calculation of a confidence interval around a difference between two proportions) (see Table 29 -3). Thus, the smallest effect of the behavioral sleep intervention that is compatible with the data is an 8% reduction in the absolute number of infants with sleep problems. If, as a clinician in a maternal and child health center, you consider it worthwhile to provide the sleep intervention to 12 mothers to resolve a single infant's sleep problems (8% is equivalent to about 1 in 12), then this represents a definitive trial.
What could you tell a mother who is considering participating in the sleep intervention? It would be reasonable to focus first on the point estimate of the intervention effect. You could inform the mother that if she does not participate, her chances of resolving the problem are about 50-50 (resolution rate in the control group was 47% or 100% minus 53% who reported residual sleep problems). If she participates, however, it is most likely that her chances of resolving the problem increase to about 70% (100% minus 30% who reported residual sleep problems). One could frame it in the opposite but equivalent way: her likelihood of persisting sleep problems drops from 53% to 30% with the behavioral What if the mother were to ask: "But nurse, are you sure the sleep program is that good?" You would have to say that no, you are not. You can be confident, however, that the chances of resolving the sleep problem will increase from 47% without the sleep program to 55% with it (47% plus the 8% that represents the lower boundary of the confidence interval around the absolute difference between intervention and control groups). If this lower boundary represents the truth, then 12 families would have to participate for a single infant to benefit (NNT = 100%/8%). If, before recommending the behavioral sleep intervention, you were to require a greater reduction than 8% in the proportion of mothers who report resolved infant sleep problems, a larger trial (with correspondingly narrower confidence intervals) would be needed.
WAS THE TRIAL LARGE ENOUGH?
As implied in our previous discussion, confidence intervals provide a way of determining whether a trial was large enough. We illustrate the approach in Figure 29-1 . 6 In this figure, each of the distribution curves represents the results of one hypothetical randomized trial of an experimental intervention to reduce mortality (trials A, B, C, and D). The solid vertical line at 0% represents an absolute risk reduction of zero, when the intervention and control groups have exactly the same mortality. Values to the right of the vertical line represent results in which the treated group had a lower mortality rate than the control group. Values to the left of the vertical line represent results in which the treated group fared worse and had a higher mortality rate than the control group.
The highest point of each distribution represents the result actually observed (the point estimate). In trials A and B, the investigators observed that mortality was 5% lower in the intervention group than in the control group. In trials C and D, they observed that mortality was 1% higher in the intervention group than in the control group.
The distributions of the likelihood of possible true results of each trial are based on the point estimate and the size of the sample. The point estimate is the single value that is most likely to represent the true effect. Values farther from the results observed are less likely than values closer to the point estimate to represent the true difference in mortality.
Suppose we assume that an absolute reduction in mortality greater than 1% warrants intervention (i.e., such a result is clinically important) and a reduction of less than 1% means that intervention is not warranted (i.e., the result is trivial). For instance, if the experimental intervention results in a true reduction in mortality from 5% to 4% or less, we would want to use the intervention. Conversely, if the true reduction in mortality was 5% to 4.5%, we would consider the benefit of the experimental intervention was not worth the associated side effects and expense. What implication does this have for the way in which we interpret the results of the four studies?
In trial A in Figure 29 -1, the entire distribution and, hence, the entire 95% confidence interval lies above the threshold risk reduction of 1%. We could be confident that the true intervention effect was above our threshold, and that we had a definitive "positive" trial. In other words, we would be very confident that the true reduction in risk was greater than 1% (and most likely, appreciably greater), a finding suggesting that many patients would be interested in receiving the intervention. The sample size in this trial would be adequate to demonstrate that the intervention provides a clinically important benefit.
Trial B in Figure 29 -1 has the same point estimate of intervention effect as trial A (5%) and is also "positive" (P < 0.05) but it includes fewer patients. In a hypothesis test, the null hypothesis (i.e., no difference between the intervention and control groups), would be rejected. However, more than 2.5% of the distribution is to the left of the 1% threshold. When the 95% confidence interval includes values less than 1%, the data are consistent with an absolute risk reduction less than 1%. We are left in doubt that the intervention effect is really greater than our threshold. This trial is still "positive," but its results would not be definitive. The sample size of this trial would be too small to establish definitively the appropriateness of administering the intervention.
Trial C in Figure 29 -1 is "negative" in that its results would not exclude the null hypothesis of "no intervention effect." The investigators would observe a mortality rate that was 1% higher in the intervention group than in the control group. The entire Unit V Understanding the Results distribution and, therefore, the 95% confidence interval lie to the left of our 1% threshold. The finding that the upper limit of the confidence interval is 1% would mean that we can be very confident that, if there is a benefit, it is very small and unlikely to be appreciably greater than the risks, costs, and inconvenience of the intervention. The trial would therefore exclude any patient-important benefit of the intervention, and it could be considered definitive. We would therefore dismiss the intervention, at least for this type of population.
The result of trial D in Figure 29 -1 shows the same difference in absolute risk as that of trial C, in which the mortality rate is 1% higher in the intervention group than in the control group. Trial D, however, had a smaller sample size and, consequently, a much wider distribution of results. Because an appreciable portion of the confidence interval lies to the right of our 1% threshold, we would conclude that it remains plausible (although unlikely) that the true effect of the intervention is a reduction in mortality greater than 1%. Although we would still refrain from using this intervention (indeed, we would conclude it most likely kills people), we would not totally dismiss it. Trial D therefore would not be definitive, and we would require larger trials enrolling more patients to exclude a clinically important intervention effect.
CONCLUSION
Confidence intervals provide the plausible range within which the true difference in outcome between an intervention and control group falls. The smaller the sample size is, the wider the confidence interval will be. As the sample size becomes very large, the confidence interval narrows, and we become increasingly certain that the truth is not far from the point estimate. In addition, confidence intervals provide us with the information we need to help us determine the likelihood that, despite the lack of a statistically significant difference, a patient-important difference is still present.
In a negative trial, the confidence interval around the difference between groups helps to determine whether the trial was large enough to exclude a patient-important benefit. If the boundary of the confidence interval most in favor of the intervention excludes any important benefit of the intervention, you can indeed conclude that the trial is definitively negative. Conversely, if the confidence interval includes an important benefit, the trial has not ruled out the possibility that the intervention may still be worthwhile. In this case, further studies with larger sample sizes are required.
In a positive trial establishing that the effect of the intervention is greater than zero, look at the smallest plausible intervention effect compatible with the data. If this smallest intervention effect is greater than the smallest difference that you consider important, the sample size is adequate, and the trial is definitive. If it is less than this smallest important difference, the trial is nondefinitive, and further trials are required.
